Epigen is discovering novel therapies for unmet medical needs. Epigen is a start-up pharmaceutical company with a mission to discover innovative, proprietary drugs for unmet medical needs. The company works in a highly collaborative translational manner, to facilitate the transition of discoveries from laboratory to clinic. Epigen uses advanced hit-to-lead and lead optimization methods, such as computational design, scaffold-hopping, focused library synthesis and screening.

SNP, miRNA, Gene Expresion. Material, Equipment and Facility Controls. EpigenDx is a genomic and epigenomic research. Our experience with EpigenDx has been excellent their technical staff will succeed even with difficult genomic regions.

Please enter your username and password. In the fields provided below to login. If you cannot remember your password, you can recover it using the link below.

Training and Career Development Activities. Building a Future for Epigenetics and Systems Biology Research in Europe. Why do we need epigenetics research. EpiGeneSys bids farewell to Denise Barlow. It is with immense sadness that we learned that this great scientist and pioneer in the field of genomic imprinting, passed away on October 21st 2017. Edith Heard chosen as new EMBL director.